PLSCR4
Phospholipid scramblase 4
Also known as: PLS4_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NRQ2
- Gene
- PLSCR4
- Ensembl
- ENSG00000114698
- Chromosome
- 3
- Canonical length
- 329 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Nucleoplasm,Nuclear bodies
OverviewNCBI Gene
Enables CD4 receptor binding activity; enzyme binding activity; and phospholipid scramblase activity. Involved in calcium activated phosphatidylcholine scrambling and calcium activated phosphatidylserine scrambling. Located in nucleus and plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
329 residues, UniProt reviewed canonical sequence.
>Q9NRQ2|PLSCR4
1 MSGVVPTAPE QPAGEMENQT KPPDPRPDAP PEYNSHFLPG PPGTAVPPPT GYPGGLPMGY
61 YSPQQPSTFP LYQPVGGIHP VRYQPGKYPM PNQSVPITWM PGPTPMANCP PGLEYLVQLD
121 NIHVLQHFEP LEMMTCFETN NRYDIKNNSD QMVYIVTEDT DDFTRNAYRT LRPFVLRVTD
181 CMGREIMTMQ RPFRCTCCCF CCPSARQELE VQCPPGVTIG FVAEHWNLCR AVYSIQNEKK
241 ENVMRVRGPC STYGCGSDSV FEVKSLDGIS NIGSIIRKWN GLLSAMADAD HFDIHFPLDL
301 DVKMKAMIFG ACFLIDFMYF ERSPPQRSRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PLSCR4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 66 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 66 nTPM
- liver: 65 nTPM
- adipose tissue: 57 nTPM
- placenta: 53 nTPM
- gallbladder: 43 nTPM
- adrenal gland: 41 nTPM
Single-cell type
- lymphatic endothelial cells: 462 nCPM
- bergmann glia: 306 nCPM
- fibro-adipogenic progenitors: 303 nCPM
- sertoli cells: 267 nCPM
- vascular endothelial cells: 220 nCPM
- mesothelial cells: 202 nCPM
Immune cell
- NK-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- midbrain: 91 nTPM
- thalamus: 87 nTPM
- medulla oblongata: 80 nTPM
- hypothalamus: 79 nTPM
- spinal cord: 75 nTPM
- white matter: 63 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PLSCR4.
Disease | ImmuneIEDB
Conditions an epitope on PLSCR4 was assayed in.
- skin melanoma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.15
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.43
- DepMap mean gene effect
- 0.18
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- calcium activated phosphatidylcholine scrambling
- calcium activated phosphatidylserine scrambling
- cellular response to lipopolysaccharide
- plasma membrane phospholipid scrambling
Molecular functions
- calcium ion binding
- CD4 receptor binding
- enzyme binding
- phospholipid scramblase activity
- SH3 domain binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PLSCR4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PLSCR4 as an antibody target. Whether an autoantibody or antibody against PLSCR4 could matter depends on whether native PLSCR4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PLSCR4 is annotated at the cell surface, where native PLSCR4 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PLSCR4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...